Unfortunately, even with the use of US contrast agents, there is considerable overlap in the appearance of metastases and hepatocellular ... colon, pancreas, or ovary (Fig. 8). Thyroid carcinoma ...

New data showed that prior malignancy may influence survival outcomes in patients with metastatic colorectal cancer, ...

First-line durvalumab with arterial chemotherapy in major portal invaded hepatocellular carcinoma: The phase 2 DurHope study with biomolecular analyses. This is an ASCO Meeting Abstract from the 2025 ...

Oncolytic viruses (OVs) are viruses that infect and kill cancer cells while sparing healthy tissue, making them a promising therapeutic option in cancer ...

Amezalpat has been granted FDA fast track designation as treatment for patients with hepatocellular carcinoma.

Amezalpat is an investigational oral, small molecule, selective peroxisome proliferator-activated receptor-alpha antagonist.

A cancer that ... to detect hepatocellular cancer at any stage. Baylor Medicine offers patients access to specialists in all areas of care for liver cancer. Patients with cancer that has spread from ...

On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...

in treatment naïve patients with unresectable locally advanced or metastatic hepatocellular carcinoma (HCC). These data are being presented at the 2025 ASCO Gastrointestinal Cancers Symposium ...

Unresectable canine hepatocellular carcinoma (HCC) has limited nonsurgical treatment options. Sorafenib is a targeted therapy for unresectable canine HCC. However, there are limited reports on the ...